Filing Details
- Accession Number:
- 0001567619-18-006700
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-11-19 19:08:33
- Reporting Period:
- 2018-11-15
- Accepted Time:
- 2018-11-19 19:08:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1433714 | Castlight Health Inc. | CSLT | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1278454 | C John Doyle | C/O Castlight Health, Inc. 150 Spear St., Suite 400 San Francisco CA 94105 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Acquisiton | 2018-11-15 | 8,250 | $0.00 | 239,602 | No | 4 | M | Direct | |
| Class B Common Stock | Disposition | 2018-11-16 | 2,872 | $2.84 | 236,730 | No | 4 | S | Direct | |
| Class B Common Stock | Acquisiton | 2018-11-16 | 7,812 | $0.00 | 244,542 | No | 4 | M | Direct | |
| Class B Common Stock | Acquisiton | 2018-11-16 | 18,750 | $0.00 | 263,292 | No | 4 | M | Direct | |
| Class B Common Stock | Acquisiton | 2018-11-16 | 23,750 | $0.00 | 287,042 | No | 4 | M | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class B Common Stock | Restricted Stock Units | Disposition | 2018-11-15 | 8,250 | $0.00 | 8,250 | $0.00 |
| Class B Common Stock | Restricted Stock Units | Disposition | 2018-11-16 | 7,812 | $0.00 | 7,812 | $0.00 |
| Class B Common Stock | Restricted Stock Units | Disposition | 2018-11-16 | 18,750 | $0.00 | 18,750 | $0.00 |
| Class B Common Stock | Restricted Stock Units | Disposition | 2018-11-16 | 23,750 | $0.00 | 23,750 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 16,500 | No | 4 | M | Direct | ||
| 39,063 | No | 4 | M | Direct | ||
| 131,250 | No | 4 | M | Direct | ||
| 308,750 | No | 4 | M | Direct |
Footnotes
- Release and settlement of restricted stock units ("RSUs") granted to the Reporting Person on June 17, 2015, the grant of which was previously reported by the Reporting Person on a Form 4.
- Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSU's. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- Represents the weighted average sales price per share. The shares sold at prices ranging from $2.84 to $2.85 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- Release and settlement of RSUs granted to the Reporting Person on February 26, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
- Release and settlement of RSUs granted to the Reporting Person on July 8, 2016, the grant of which was previously reported by the Reporting Person on a Form 4.
- Release and settlement of RSUs granted to the Reporting Person on February 15, 2018, the grant of which was previously reported by the Reporting Person on a Form 4.
- Each RSU represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
- The RSUs vest over 4 years as follows: 25% of the RSUs vested on May 15, 2016 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting.
- The RSUs vest over 4 years as follows: 25% of the RSUs vested on February 16, 2017 and the remainder will vest on each quarterly anniversary thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- 25% of the RSUs vested on August 16, 2017 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- The RSUs will vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
Billionaire Hedge Funds
